BN Business News
Add your company to Business Communicator →

Business · 17/09/2025

FDA Announces Draft Guidance for Developing Drugs for Disseminated Coccidioidomycosis

The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for disseminated coccidioidomycosis, a serious fungal infection caused by Coccidioides species.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights